CSCs are crucial in cancer treatment because they are often resistant to standard therapies such as chemotherapy and radiation. These treatments typically target rapidly dividing cells but may not effectively eradicate CSCs, leading to tumor recurrence and metastasis. By understanding the unique properties of CSCs, researchers aim to develop targeted therapies that can specifically eliminate these resilient cells and improve patient outcomes.
